Endoscopic transcortical expanded transforaminal transvenous transchoroidal approach to third ventricle lesion resection using an endoport. (December 2022)
- Record Type:
- Journal Article
- Title:
- Endoscopic transcortical expanded transforaminal transvenous transchoroidal approach to third ventricle lesion resection using an endoport. (December 2022)
- Main Title:
- Endoscopic transcortical expanded transforaminal transvenous transchoroidal approach to third ventricle lesion resection using an endoport
- Authors:
- Liu, Teng-Fei
Shen, Wen-Jun
Chen, Yi-Min
Xie, Tao
Hu, Fan
Li, Chen
Liu, Shuang
Li, Ze-Yang
Yang, Liang-Liang
Wu, Si-lin
Ye, Yu-Yang
Zhang, Xiao-Biao - Abstract:
- Highlights: Preliminary application of combined endoscopy, endoport, and expanded transforaminal transvenous transchoroidal approach with third ventricle tumors. Elaborating the advantages of using endoport technology and recommendations. Putting forward our views and experience on whether to sever the anterior septal vein. Some key points are proposed for the surgical approach. Abstract: Objective: To investigate the clinical experience and application value of endoscopic resection of lesions in and around the third ventricle using a transcortical expanded transforaminal transvenous transchoroidal approach with an endoport. Methods: Clinical data and follow-up results of seven patients who underwent the removal of lesions in the third ventricle and its adjacent area with an endoport-guided endoscopic system from January 2018 to December 2020 in the Department of Neurosurgery, Zhongshan Hospital Affiliated to Fudan University, were analyzed retrospectively. Two other patients from the Affiliated Pediatric Hospital of Fudan University and the Affiliated Hospital of Guizhou Medical University, respectively, were included in the analysis. Results: A total of nine cases of third ventricle tumors were included in the study, including six women and three men, with an average age of 37.8 years (4–84 years old) and a follow-up time of 6–44 months. These nine tumor cases included two pilocytic astrocytomas, one diffuse midline glioma (H3 K27-altered), two craniopharyngiomas, twoHighlights: Preliminary application of combined endoscopy, endoport, and expanded transforaminal transvenous transchoroidal approach with third ventricle tumors. Elaborating the advantages of using endoport technology and recommendations. Putting forward our views and experience on whether to sever the anterior septal vein. Some key points are proposed for the surgical approach. Abstract: Objective: To investigate the clinical experience and application value of endoscopic resection of lesions in and around the third ventricle using a transcortical expanded transforaminal transvenous transchoroidal approach with an endoport. Methods: Clinical data and follow-up results of seven patients who underwent the removal of lesions in the third ventricle and its adjacent area with an endoport-guided endoscopic system from January 2018 to December 2020 in the Department of Neurosurgery, Zhongshan Hospital Affiliated to Fudan University, were analyzed retrospectively. Two other patients from the Affiliated Pediatric Hospital of Fudan University and the Affiliated Hospital of Guizhou Medical University, respectively, were included in the analysis. Results: A total of nine cases of third ventricle tumors were included in the study, including six women and three men, with an average age of 37.8 years (4–84 years old) and a follow-up time of 6–44 months. These nine tumor cases included two pilocytic astrocytomas, one diffuse midline glioma (H3 K27-altered), two craniopharyngiomas, two choroid plexus (CP) papillomas, one germinoma, and one pineal parenchymal tumor of intermediate differentiation. Total resection was completed in eight cases, with one near-total resection. There were no complications related to the surgical approach, such as epilepsy, aphasia, or hemiplegia. Conclusions: The endoscope transcortical expanded transforaminal transvenous transchoroidal approach using an endoport can safely and effectively remove third ventricle lesions. This approach can reach a wide area, from the anterior to the posterior third ventricle. … (more)
- Is Part Of:
- Journal of clinical neuroscience. Volume 106(2022)
- Journal:
- Journal of clinical neuroscience
- Issue:
- Volume 106(2022)
- Issue Display:
- Volume 106, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 106
- Issue:
- 2022
- Issue Sort Value:
- 2022-0106-2022-0000
- Page Start:
- 166
- Page End:
- 172
- Publication Date:
- 2022-12
- Subjects:
- Transforaminal approach -- Transchoroidal approach -- Neuroendoscopy -- Third ventricle
ASV anterior septal vein -- CP choroid plexus -- ICV internal cerebral vein -- TSV thalamostriate vein
Brain -- Surgery -- Periodicals
Neurosciences -- Periodicals
Nervous system -- Surgery -- Periodicals
Brain -- surgery -- Periodicals
Neurosurgical Procedures -- Periodicals
Neurosciences -- Periodicals
Electronic journals
616.8 - Journal URLs:
- http://www.harcourt-international.com/journals ↗
http://www.sciencedirect.com/science/journal/09675868 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09675868 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jocn.2022.10.025 ↗
- Languages:
- English
- ISSNs:
- 0967-5868
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4958.585000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24339.xml